http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002035106-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3b0a3dbf8d6c9712d86ea1383fd5327 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C04B12-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-838 |
| filingDate | 2000-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b20aaa94869965484514b4a854d064d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_814af514084a2943a18850ca323c8362 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b281b664984d71c6f4af08a59ae4e31 |
| publicationDate | 2002-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002035106-A |
| titleOfInvention | Calcium phosphate cement capable of forming high-strength cured body for bone augmentation treatment of living body |
| abstract | (57) [Problem] To provide a calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body. SOLUTION: The calcium phosphate cement for bone augmentation treatment of a living body is expressed by mass% of magnesium phosphate: 0.03 to 0.5%, hydration reaction product of dibasic calcium phosphate and α-type tribasic calcium phosphate: 2 to 10%, dibasic calcium phosphate: 3 to 10%, quaternary calcium phosphate: 10 to 2 5%, α-type tribasic calcium phosphate and inevitable impurities: The remainder is composed of a mixed composition having a compounding composition consisting of: |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642934-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015020192-A1 |
| priorityDate | 2000-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.